
Medical/Dental Affairs: Sickle Cell Disease & Delayed Hemolytic Transfusion Reaction - October 27, 2025
Claiming Credit
Thank you for participating in this program. Once logged in, please click on "Take Course" or "Register" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.
You must have attended the October 27, 2025, program to claim credit.
Target Audience
BMC/BUMG Medical-Dental Staff
Learning Objectives
At the end of this session learners will be able to:
- Assess if a hemoglobin level is critical to require transfusion in a patient with sickle cell disease, and be able to EMR to locate a care plan.
- Identify key parameters to prior transfusion in a patient with sickle cell disease.
- Identify clinical signs and symptoms of delayed hemolytic transfusion reaction.
- Management of a delayed hemolytic transfusion reaction.
BU CCE Program Manager: Naomi Moeller
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation

Facebook
X
LinkedIn
Forward